Skip to main content
NVDA-2.15%AAPL+1.33%GOOGL-0.14%MSFT-0.19%AMZN-0.04%TSM-1.84%SPCX+1.81%AVGO-0.20%META-0.07%TSLA-0.22%SKHY-4.72%MU-3.43%BRK-B+0.06%LLY+0.60%JPM-0.43%AMD-2.31%WMT+0.81%V-0.29%XOM-0.46%ASMLa-2.21%JNJ+0.11%INTC-5.28%MA-0.24%0700.HK-1.94%ORCL-2.05%1398.HK+0.79%BAC-0.09%ABBV+0.77%CSCO-0.26%CVX-1.01%COST+0.14%LRCX-3.69%KO+1.14%CAT-0.70%AMAT-1.87%0005.HK-0.78%AP2d-1.11%UNH+0.33%DELL-3.31%HSBA.L-0.98%MS+0.02%PG+0.08%GE+0.44%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.20%HD-0.86%GS-0.13%0939.HK+1.66%NZDJPY-2.67%AUDJPY-1.96%CHFJPY-1.68%USDJPY-1.52%GBPJPY-1.47%CADJPY-1.45%EURJPY-1.43%EURNZD+1.28%NZDCAD-1.23%GBPNZD+1.22%NZDUSD-1.18%NZDCHF-1.02%USDNOK+0.96%EURNOK+0.88%CHFNOK+0.85%NOKJPY-0.75%AUDNZD+0.74%USDZAR+0.67%USDSEK+0.61%EURZAR+0.58%USDMXN+0.57%AUDDKK-0.56%AUDCAD-0.54%EURAUD+0.54%EURSEK+0.53%CHFSEK+0.49%GBPZAR+0.49%AUDSGD-0.48%GBPAUD+0.48%AUDUSD-0.45%GBPTRY+0.41%USDTHB+0.38%GBPHKD+0.32%AUDNOK+0.31%NZDSGD-0.29%GBPMXN-0.28%AUDCHF-0.28%USDPLN+0.27%EURCHF+0.24%CADCHF+0.21%GBPCHF+0.20%EURPLN+0.19%USDCHF+0.17%USDSGD+0.17%USDILS+0.16%USDTRY+0.11%EURHKD-0.10%NZDMXN+0.10%USDDKK+0.09%EURSGD+0.08%EURUSD+0.08%PLNJPY-0.06%USDCAD-0.06%GBPUSD+0.05%EURGBP+0.05%EURCZK-0.05%CHFSGD+0.05%SGDJPY+0.05%USDCOP-0.04%USDCNH+0.03%GBPCAD-0.03%EURCNH-0.03%EURCAD+0.02%GBPSGD-0.02%USDHKD0.00%EURDKK0.00%XPTUSD-4.05%HG1-4.03%GAGUSD-3.64%XAGUSD-3.64%UKOIL+1.91%COFFEE-1.84%USOIL+1.73%W1-0.92%COCOA-0.78%GAUUSD-0.64%XAUUSD-0.63%C1-0.56%BTCUSD-1.24%ETHUSD-1.02%USDTUSD-0.06%XRPUSD-1.98%SOLUSD-1.46%TRXUSDT0.00%ZECUSDT-5.46%DOGEUSD-2.43%XMRUSDT-1.64%LINKUSD-0.97%XLMUSD-1.58%BCHUSDT-9.07%LTCUSD-1.45%UNIUSD-3.79%HBARUSDT-1.63%TONUSD+24.88%SUIUSD-2.90%TAOUSDT-4.20%AAVEUSD-2.75%DOTUSDT-3.16%ICPUSDT-0.72%ONDOUSDT-2.53%WLDUSDT-2.43%ATOMUSDT-3.24%ARBUSDT+1.19%JUPUSDT-2.53%INJUSDT-3.51%STXUSDT-3.07%FETUSDT-2.98%TIAUSDT-0.34%PYTHUSDT-0.58%SEIUSDT-3.91%IMXUSDT-3.06%WIFUSDT-3.91%GRTUSDT-2.81%OPUSDT-3.00%IOTAUSDT-3.05%POLUSDT-6.22%AXSUSDT-2.25%FARTCOINUSDT-1.70%EOSUSDT-1.18%DYDXUSDT-0.88%ORDIUSDT-0.21%GALAUSDT-3.65%NOTUSDT-1.83%RONINUSDT-2.64%NVDA-2.15%AAPL+1.33%GOOGL-0.14%MSFT-0.19%AMZN-0.04%TSM-1.84%SPCX+1.81%AVGO-0.20%META-0.07%TSLA-0.22%SKHY-4.72%MU-3.43%BRK-B+0.06%LLY+0.60%JPM-0.43%AMD-2.31%WMT+0.81%V-0.29%XOM-0.46%ASMLa-2.21%JNJ+0.11%INTC-5.28%MA-0.24%0700.HK-1.94%ORCL-2.05%1398.HK+0.79%BAC-0.09%ABBV+0.77%CSCO-0.26%CVX-1.01%COST+0.14%LRCX-3.69%KO+1.14%CAT-0.70%AMAT-1.87%0005.HK-0.78%AP2d-1.11%UNH+0.33%DELL-3.31%HSBA.L-0.98%MS+0.02%PG+0.08%GE+0.44%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.20%HD-0.86%GS-0.13%0939.HK+1.66%NZDJPY-2.67%AUDJPY-1.96%CHFJPY-1.68%USDJPY-1.52%GBPJPY-1.47%CADJPY-1.45%EURJPY-1.43%EURNZD+1.28%NZDCAD-1.23%GBPNZD+1.22%NZDUSD-1.18%NZDCHF-1.02%USDNOK+0.96%EURNOK+0.88%CHFNOK+0.85%NOKJPY-0.75%AUDNZD+0.74%USDZAR+0.67%USDSEK+0.61%EURZAR+0.58%USDMXN+0.57%AUDDKK-0.56%AUDCAD-0.54%EURAUD+0.54%EURSEK+0.53%CHFSEK+0.49%GBPZAR+0.49%AUDSGD-0.48%GBPAUD+0.48%AUDUSD-0.45%GBPTRY+0.41%USDTHB+0.38%GBPHKD+0.32%AUDNOK+0.31%NZDSGD-0.29%GBPMXN-0.28%AUDCHF-0.28%USDPLN+0.27%EURCHF+0.24%CADCHF+0.21%GBPCHF+0.20%EURPLN+0.19%USDCHF+0.17%USDSGD+0.17%USDILS+0.16%USDTRY+0.11%EURHKD-0.10%NZDMXN+0.10%USDDKK+0.09%EURSGD+0.08%EURUSD+0.08%PLNJPY-0.06%USDCAD-0.06%GBPUSD+0.05%EURGBP+0.05%EURCZK-0.05%CHFSGD+0.05%SGDJPY+0.05%USDCOP-0.04%USDCNH+0.03%GBPCAD-0.03%EURCNH-0.03%EURCAD+0.02%GBPSGD-0.02%USDHKD0.00%EURDKK0.00%XPTUSD-4.05%HG1-4.03%GAGUSD-3.64%XAGUSD-3.64%UKOIL+1.91%COFFEE-1.84%USOIL+1.73%W1-0.92%COCOA-0.78%GAUUSD-0.64%XAUUSD-0.63%C1-0.56%BTCUSD-1.24%ETHUSD-1.02%USDTUSD-0.06%XRPUSD-1.98%SOLUSD-1.46%TRXUSDT0.00%ZECUSDT-5.46%DOGEUSD-2.43%XMRUSDT-1.64%LINKUSD-0.97%XLMUSD-1.58%BCHUSDT-9.07%LTCUSD-1.45%UNIUSD-3.79%HBARUSDT-1.63%TONUSD+24.88%SUIUSD-2.90%TAOUSDT-4.20%AAVEUSD-2.75%DOTUSDT-3.16%ICPUSDT-0.72%ONDOUSDT-2.53%WLDUSDT-2.43%ATOMUSDT-3.24%ARBUSDT+1.19%JUPUSDT-2.53%INJUSDT-3.51%STXUSDT-3.07%FETUSDT-2.98%TIAUSDT-0.34%PYTHUSDT-0.58%SEIUSDT-3.91%IMXUSDT-3.06%WIFUSDT-3.91%GRTUSDT-2.81%OPUSDT-3.00%IOTAUSDT-3.05%POLUSDT-6.22%AXSUSDT-2.25%FARTCOINUSDT-1.70%EOSUSDT-1.18%DYDXUSDT-0.88%ORDIUSDT-0.21%GALAUSDT-3.65%NOTUSDT-1.83%RONINUSDT-2.64%
BS

BioNTech SE (BNTX)

NASDAQ • Healthcare

$96.6
-$1.52 (-1.6%)
Market open

September 10, 2026 at 14:29 UTC

Open$98.5
Previous Close$98.13
Day Range$96.87 - $98.64
Avg. Volume (3M)1.7M
Market Cap$24.6B
52 Week Range
$79.52$124
Next EarningsIn 54 daysNov 3, 2026

Interactive Chart

14:29:32 UTC

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$105.6M100%
Gross Profitminus cost of goods$8.6M8%

Fundamentals & Financials

Revenue (TTM)
$2.6B
Net Income (TTM)
-$1.6B
EPS (TTM)
-$6.73
ROA (TTM)
-8.34%
Current Ratio
7.85
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-556.7%Q1 2026-$1.44
+4.4%Q2 2026-$2.43
-54.3%Q3 2026-$3.7
Next

Nov 3

in 54 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -54.3%

BioNTech’s adjusted EPS missed consensus in the second fiscal quarter of 2026, based on preliminary results reported Aug. 4. Adjusted EPS came in at EUR -2.58 versus the EUR -2.40 estimate, about -7.6%, and was down from EUR -1.82 a year earlier. Operating income was a loss of about EUR 752.5 million, while net income fell 115.8% to a loss of about EUR 834.4 million from a loss of EUR 386.6 million a year ago. Operating cash flow was about EUR 11 million. Consensus for the next period calls for EPS of EUR 0.85 and revenue of EUR 1.22 billion.

View full earnings history

About BioNTech SE

BioNTech SE (NASDAQ: BNTX) is a biotechnology company focused on immune-based treatments for cancer and infectious disease, spanning oncology programs, infectious-disease immunotherapies, and protein replacement therapies for rare conditions. The company generated EUR 2.8 billion of revenue in FY2025, with principal operations in Mainz, Germany.

Name
BioNTech SE
CEO
Ugur Sahin
Website
www.biontech.com
Industry
Healthcare
Year Founded
2008
Employees
7,807

Today's Snapshot

AI-generated

Yesterday BNTX fell 0.5% to 98.13.

Trading Volume

Below 10d avg (1.2M)

706.5K

vs S&P 500 Today

Inline with Market

-0.06%

Updated: September 10, 2026 at 12:28 UTC

BNTX Headlines

BioNTech ends Phase 2 colorectal cancer trial

August 28, 2026

2 min read

DACH-Focused Stock Moves Across Key Sectors

March 21, 2026

5 min read

Markets Swoon as Bitcoin, Tech and Crypto Firms Slide

February 5, 2026

5 min read
View All News

Technical Indicators

2 Buy2 Neutral4 Sell
BNTX presents a mixed but overall bearish technical footprint with the price around 98.13 sitting below the 10–20 day averages yet near longer-term moving averages and the classic pivot at 99.39. Momentum readings are conflicted—short-term oscillators register oversold or buy signals while raw momentum is negative—and MACD is muted, suggesting limited follow-through. Trend strength is modest per ADX and volatility is unchanged, while on-balance volume is negative, which weighs on bullish arguments. Technical takeaway: Conflicting short-term signals against weakening volume and pivot resistance support an overall sell bias.
All signals
  • EMA (5 indicators)$96.99 - $102.40
    Sell
  • RSI (14)45.38
    Neutral
  • Stochastic %K (14, 3, 3)17.01
    Buy
  • MACD Level (12, 26)1.45
    Neutral

Peers & Related Assets

NTRANatera, Inc.
$330.31+1.9%
DXCMDexCom, Inc.
$83.88-0.8%
BIIBBiogen Inc.
$210.73-0.8%
RPRXRoyalty Pharma plc
$60.590.0%
INCYIncyte Corporation
$126.01+1.3%
UTHRUnited Therapeutics Corporation
$506.82+1.8%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.